Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinflunine as Salvage Chemotherapy in HRPC
NCT00545766Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- May 2007
- Primary completion
- Jan 2008
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinflunine in prostate cancer (PCa), sponsored by SCRI Development Innovations. Started May 2007; status: completed.
02
Drugs
vinflunine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00545766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545766.